Search

You searched for "Outcomes"

1296 results found

First UK hypoglossal nerve stimulation implant in the treatment for moderate to severe OSA

25 April 2023 | | ENTA - ENT, ENTA - Laryngology / Swallowing / Voice
Obstructive sleep apnoea has been treated in many different ways over the years. We hear from Yakubu Karagama about one of the latest surgical developments. Introduction Obstructive sleep apnoea (OSA) is by far the most common sleep disorder, affecting all...

Mucormycosis: In conversation with Dr Deepak Haldipur and Dr Aditya Moorthy

7 July 2021 | | ENTA - Covid-19, ENTA - ENT, ENTA - Rhinology / Sinus
COVID-19 has ravaged the world in the past 18 months. The second wave in many countries was deadlier than the first. Mucormycosis, infamously labelled ‘the black fungus’ has affected some countries, such as India, in epidemic proportions within this COVID...

Audiological monitoring in ototoxicity - Are we doing enough?

1 November 2016 | | ENTA - Audiology - Adult
In this article Ghada Al-Malky explores the dichotomy of life-saving, yet hearing loss-causing medication, and questions whether the hearing healthcare community is doing enough to prevent preventable hearing loss. Ototoxicity is the damage to hearing and / or balance functions...

Retrieval of an aspirated voice prosthesis in the awake laryngectomised patient

3 March 2021 | | ENTA - ENT, ENTA - Laryngology / Swallowing / Voice
In this article, the authors describe a simple and effective technique for extracting an aspirated voice prosthesis from within the tracheobronchial tree in the awake laryngectomised patient using the Ambu® aScopeTM 4 Broncho endoscope. Surgical voice restoration remains the dominant...

Ethics, conduct and sinonasal surgery

10 March 2023 | | ENTA - ENT, ENTA - Rhinology / Sinus
For the three plenary sessions at ERS 2023, we asked top leaders in the field to enlighten us in the general aspects of our profession that need attention. Prof Gil Siegal will discuss the ethical questions we encounter in our...

Reflections on educational gatherings in the COVID era

9 September 2020 | | ENTA - Covid-19, ENTA - ENT
The COVID pandemic has brought disruption and uncertainty for the organisers of medical conferences. ENT and audiology have always thrived on a healthy exchange of views and the sharing of knowledge across subspecialties and across national boundaries. Ray Clarke asked...

Endoscopic CSF leak repair using nasoseptal flap

1 May 2019 | | ENTA - ENT, ENTA - Rhinology / Sinus
Many of us during training or in established practice will have encountered the complication of anterior skull base CSF leak. This can be a challenging problem to deal with and in this article the authors describe their favoured approach. Cerebrospinal...

Current management of unilateral sporadic vestibular schwannoma

10 March 2023 | | ENTA - Audiology - Adult, ENTA - Skull Base Surgery, ENTA - Vestibular Disorders
Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

6 June 2017 | | ENTA - Audiology - Adult, ENTA - Audiology - Paediatric, ENTA - Auditory Implants, ENTA - ENT, ENTA - Otology, ENTA - Paediatrics
Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

Monitored safe medical practice: minimising patient harm will reduce medical negligence bill for the NHS

1 September 2018 | | ENTA - ENT
Patrick Bradley ruminates on a celebrated career in ENT head and neck surgery and suggests that increasing the possibility of positive outcomes to contemporary patient safety initiatives by the NHS must involve efforts to develop an enthusiastic contented workforce willing...

Chronic rhinosinusitis management: back to the future?

1 July 2016 | | ENTA - ENT, ENTA - Rhinology / Sinus
Immunology is a dim and distant medical school memory to many ENT surgeons, but the increasingly complex immunology of chronic rhinosinusitis is fascinating (honestly!). Medical management options in CRS no longer just involves saline and steroids, and we need to...

Systemic agents in thyroid cancer

1 July 2017 | | ENTA - ENT, ENTA - Head & Neck, ENTA - Thyroid / Parathyroid Surgery
For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...